PainReform Ltd.
PRFX · NASDAQ
6/30/2025 | 3/31/2025 | 12/31/2024 | 9/30/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.00 | 0.12 | 0.00 | 0.01 |
| FCF Yield | -32.42% | -21.61% | -40.24% | -54.74% |
| EV / EBITDA | 0.33 | -1.06 | -0.83 | 0.66 |
| Quality | ||||
| ROIC | -13.51% | -13.51% | -40.57% | -41.42% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 0.86 | 0.86 | 2.25 | 2.25 |
| Growth | ||||
| Revenue 3-Year CAGR | -100.00% | -100.00% | -100.00% | -78.31% |
| Free Cash Flow Growth | 0.00% | 50.18% | 0.00% | 59.85% |
| Safety | ||||
| Net Debt / EBITDA | 3.13 | 3.13 | 4.80 | 4.80 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | 0.00 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |